Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07401186 · ClinicalTrials.gov registry record · NA

Stimulation-Based Modulation of Spinal and Cortical Sensory Pathways

A NA study of Stroke and Able Bodied, sponsored by Peter C. Gerszten, MD.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07401186 is a NA study of Stroke and Able Bodied that is actively recruiting participants, run by Peter C. Gerszten, MD. The registered enrollment target is 15 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07401186, a NA study of Stroke and Able Bodied, is actively recruiting participants, sponsored by Peter C. Gerszten, MD.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess cervical (neck) reflexes by intra-operatively stimulating the neck nerve roots to evoke motor responses through their connections to spinal motoneurons. This data is critical to reveal changes to the spinal sensory modulating circuitry in neurological disorders like stroke.

Conditions Studied

Interventions

  • DEVICE Bipolar Neural Stimulation Electrode

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2026-05
Est. Completion 2028-01
Phase NA

Sponsor

Peter C. Gerszten, MD

1 total trials

What the Registry Record Tells You About NCT07401186

The ClinicalTrials.gov registry entry for NCT07401186 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Peter C. Gerszten, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Bipolar Neural Stimulation Electrode is the first listed.

NCT07401186 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07401186 about?

NCT07401186 is a clinical study titled "Stimulation-Based Modulation of Spinal and Cortical Sensory Pathways". The goal of this study is to assess cervical (neck) reflexes by intra-operatively stimulating the neck nerve roots to evoke motor responses through their connections to spinal motoneurons. This data is critical to reveal changes to the spinal sensory modulating circuitry in neurological disorders li...

What is the current status of trial NCT07401186?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-05. Estimated completion is 2028-01.

What conditions does trial NCT07401186 study?

This clinical trial studies the following conditions: Stroke, Able Bodied.

What interventions are being tested in trial NCT07401186?

The interventions under investigation include: Bipolar Neural Stimulation Electrode (DEVICE).

Who is sponsoring clinical trial NCT07401186?

This trial is sponsored by Peter C. Gerszten, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07401186 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.